BREAKING: Sanofi C$294M AI Centre of Excellence — Toronto ANTHROPIC: $1.5B JV Blackstone + Goldman Sachs — May 4, 2026 PENTAGON REFUSED — Anthropic sues US government — declared supply chain risk CLAUDE #1 App Store — 149K vs 124K ChatGPT daily downloads ANTHROPIC beats OpenAI: $30B vs $25B annualized revenue — Bloomberg AI ANTIBIOTIC Halicin: 100M molecules screened in days — MIT Science BREAKING: Sanofi C$294M AI Centre of Excellence — Toronto ANTHROPIC: $1.5B JV Blackstone + Goldman Sachs — May 4, 2026 PENTAGON REFUSED — Anthropic sues US government — declared supply chain risk CLAUDE #1 App Store — 149K vs 124K ChatGPT daily downloads ANTHROPIC beats OpenAI: $30B vs $25B annualized revenue — Bloomberg AI ANTIBIOTIC Halicin: 100M molecules screened in days — MIT Science
🤖
Business Insight Report · May 4, 2026 · Real-time Intelligence

ETHICS is the Main

"We believe AI will be transformative — and that how it is built matters as much as what it can do."

Anthropic — Mission Statement · Founded 2021
Anthropic — founded by Dario Amodei after leaving OpenAI over safety disagreements. Now valued at $900B.
Constitutional AI — Claude is trained on principles, not just data. Hard red lines: no autonomous weapons, no mass surveillance.
Revenue surpasses OpenAI — $30B vs $25B annualized. Claude Code holds 54% of AI dev tools market. 8 of Fortune 10 are clients.
🏭 Sanofi C$294M
🤝 Anthropic JV $1.5B
⚖️ Pentagon Refused
Scroll to explore
Three Events · One Day

May 4, 2026 — The Tipping Point

SANOFI · TORONTO
C$294M
AI Centre of Excellence Expansion
Canada's largest biopharma doubles down on AI. 50 new high-skilled roles by 2028. Solutions scaled across 90+ countries. Goal: halve the time from molecule discovery to patient delivery.
newswire.ca · May 4, 2026
ANTHROPIC · FINANCE
$1.5B
JV with Blackstone + Goldman Sachs
Enterprise AI at scale — before IPO. Hellman & Friedman, Goldman and Blackstone each contribute $300M. Access to thousands of portfolio companies. Demand exceeds any single delivery model.
WSJ · Bloomberg · May 4, 2026
PENTAGON · ETHICS
$200M
Anthropic Refused. Won the World.
Declined Pentagon contract over autonomous weapons and mass surveillance. Declared 'supply chain risk' by Trump — a label reserved for foreign adversaries. Filed lawsuit. Then went #1 on App Store within days.
CNN · Fortune · March–May 2026
"AI is no longer a technology — it is becoming an institution. And every institution must choose its values."
Anthropic · 2021–2026

A Strategy Built on Principles

2021
Founded — Exit from OpenAI
Dario Amodei and team left over safety governance disagreements. Mission: AI that benefits humanity without catastrophic risk. Introduced Constitutional AI — training Claude on principles first.
Oct 2025
Claude for Life Sciences
Connectors to PubMed, ChEMBL, Benchling, bioRxiv. Full journey from discovery to patient. Sanofi deploys Claude globally. FutureHouse, EvolutionaryScale, Broad Institute partnerships.
Jan 2026
Claude for Healthcare + Series G
HIPAA-ready, ICD-10, ClinicalTrials.gov integration. Valuation reaches $380B at Series G. Revenue growing faster than any AI company in history.
Feb 2026
Pentagon Refusal + Lawsuit
Refused autonomous weapons and mass surveillance. Lost $200M. Declared 'supply chain risk'. Filed suit against US government. Claude becomes #1 App Store & Google Play within days.
Apr 2026
Coefficient Bio — $400M
Enters drug discovery at the molecular level. Team from Genentech/Roche, publications in Science. Goal: autonomous drug pipeline proposals directly inside Claude.
May 4, 2026
JV $1.5B · Valuation $900B
Ethics proved to be the best business. Revenue surpasses OpenAI — $30B vs $25B. Claude Code holds 54% of AI dev tools market. 8 of Fortune 10 are customers.
AI Drug Discovery · Real Results

From Theory to Real Patients

🦠
Halicin
MIT · 2020
First AI-discovered antibiotic. 100 million molecules screened in days — humans would need decades. Active against drug-resistant bacteria.
PUBLISHED · Science
🫁
Rentosertib
Insilico Medicine · Phase IIa ✓
Pulmonary fibrosis. First drug with both AI-discovered target AND AI-designed molecule simultaneously. Positive Phase IIa clinical results.
PHASE IIa COMPLETE
⚡
ISM5411
Insilico · 12 months concept→clinic
Concept to clinic in 12 months. Traditional path: 4–6 years. AI acceleration: 4–6×. Precision-targeted molecular design from scratch.
4–6× FASTER
🧬
DDR1 Inhibitor
Insilico GAN · 21 days
Generative AI (GENTRL): data collection → model training → active molecule. Full discovery cycle completed in just 21 days. Published in Nature Biotechnology.
21 DAYS · NATURE BIOTECH
🏆
Zasocitinib
Schrödinger · Phase III ✓
TYK2 inhibitor for autoimmune conditions. Physics simulation + machine learning design. Late-stage clinical trials — one step from regulatory approval.
PHASE III · PIVOTAL
🔬
15M Compounds
Novartis · 1 experiment
Generative AI designed 15 million potential compounds in a single experiment — including predictive models for blood-brain barrier penetration. Unprecedented scale.
15M MOLECULES · 1 RUN
After Refusing the Pentagon

Ethics Pays Off — The Numbers

#1
App Store & Google Play
Feb 28, 2026
149K
daily downloads
vs 124K ChatGPT
+297%
web traffic
year over year
×2
paid subscribers
since Jan 2026
$30B
vs OpenAI $25B
annualized Q1 2026
54%
Claude Code
AI dev tools
OpenAI
–Quietly removed military use ban from Terms of Service
–Signed with Pentagon "for all lawful purposes"
–Won the $200M contract
–Altman himself: "opportunistic and sloppy"
–"We don't know why Anthropic couldn't reach this deal"
Anthropic ❤️
✓Refused autonomous weapons use
✓Refused mass surveillance of citizens
✓Lost $200M — filed lawsuit against US government
✓Declared 'supply chain risk' (label for foreign adversaries)
✓Became #1 App Store. $900B valuation. Beat OpenAI on revenue.
The Core Insight

Ethics = Best Business

LOST
$200M Pentagon contract
→
WON
$900B company valuation
LOST
Federal contracts + government support
→
WON
#1 App Store worldwide
LOST
Trump administration trust
→
WON
World trust and loyalty
INVESTED
Constitutional AI + hard red lines from day one
→
GOT
×7 enterprise growth in one year
BUILT
Claude on principles, not just training data
→
GOT
$30B revenue — surpassed OpenAI
"A smart person without ethics is dangerous. A smart person with ethics changes the world."
Conclusion
We are building
a new kind of being.

AI will educate children, heal people, make life decisions, and be present in moments of loneliness.

What values will we put inside it?

🧬
AI already saves lives. Halicin, Rentosertib, 15 million compounds in one run. The drug discovery revolution is not coming — it is here.
❤️
Ethics is not a cost. It is the highest-ROI strategy of the AI era. $200M lost → $900B won. The market voted with dollars and downloads.
🌍
Humans want human AI. When you choose an AI, you choose whose values will be with you. 4 in 5 Americans: humans, not machines, decide on lethal force.